0000950103-15-002957.txt : 20150414 0000950103-15-002957.hdr.sgml : 20150414 20150414160717 ACCESSION NUMBER: 0000950103-15-002957 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150414 FILED AS OF DATE: 20150414 DATE AS OF CHANGE: 20150414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Affimed N.V. CENTRAL INDEX KEY: 0001608390 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36619 FILM NUMBER: 15769310 BUSINESS ADDRESS: STREET 1: IM NEUENHEIMER FELD 582, 69120 CITY: HEIDELBERG STATE: 2M ZIP: 000000 BUSINESS PHONE: 49-6221-65307 MAIL ADDRESS: STREET 1: IM NEUENHEIMER FELD 582, 69120 CITY: HEIDELBERG STATE: 2M ZIP: 000000 FORMER COMPANY: FORMER CONFORMED NAME: Affimed Therapeutics B.V. DATE OF NAME CHANGE: 20140516 6-K 1 dp55264_6k.htm FORM 6-K Unassociated Document
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
 
FORM 6-K
__________________

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

For the month of April, 2015

Commission File Number: 001-36619
__________________________________

Affimed N.V.
__________________________________

Im Neuenheimer Feld 582,
69120 Heidelberg,
Germany
(Address of principal executive offices)
__________________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F ☒                          Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐
 
 
 
 
 
 
 
 
AFFIMED N.V.

On April 11, 2015, Dr. Frank Mühlenbeck advised our company that he will not stand for re-election at the upcoming 2015 Annual General Meeting of Shareholders, ending his service as a supervisory director of our company on the date of the meeting. Our supervisory board has been advised by Dr. Mühlenbeck that such decision is not due to any disagreement with our company. Our supervisory board thanks Dr. Mühlenbeck for his dedication and contributions to our company.
 
 
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in Heidelberg, Germany, April 14, 2015.
 
 
AFFIMED N.V.
  
     
     
 
By:
/s/ Adi Hoess
  
   
Name:
Adi Hoess
  
   
Title:
Chief Executive Officer
  
         
         
 
By:
/s/ Florian Fischer
  
   
Name:
Florian Fischer
  
   
Title:
Chief Financial Officer